March, 2008
Cureline Newsletter
Visit us at the Molecular Medicine Tri-conference, Booth 318
March, 2008
In This Issue
- Cureline Inc. founded in 2007 Cureline BioPathology a Human Tumor Tissues">research histology laboratory
- Visit us at the Molecular Medicine Tri-Conference
Quick Links
- Cureline Inc
- Cureline Biopathology
- Custom Tissue Acquisition
Dear Colleague:
Cureline Inc. is a global biosample management company providing effective solutions for scientifically challenging projects.
Since 2003, our team has developed multi-site international collaborations and has implemented protocols for obtaining, handling and processing of human specimens to ensure reproducible and reliable results.
Cureline Inc. founded in 2007 Cureline BioPathology, a Human Tumor Tissues">research histology laboratory
We look forward to discussing with you your projects and to meeting you at the Molecular Medicine Tri-Conference in San Francisco.
Olga Potapova, PhD
President and Scientific Director
Cureline founded in 2007 Cureline Biopathology a Human Tumor Tissues">research histology laboratory
Cureline BioPathology was founded by Cureline to leverage the already established relationships with clinical sites alliance partners and biopharmaceutical community.
Together the companies offer a complete portfolio of services in human tissue research including biospecimen acquisition, storage and comprehensive histology analysis using special stains and immunohistochemical methods.
For detailed information about Cureline BioPathology services and prices, visit www.curelinebiopathology.com.
Visit us at the Molecular Medicine Tri-conference in San Francisco
We will present our capabilities at the Molecular Medicine Tri-Conference in San Francisco (March 25-March 28, 2008).
We welcome you to visit our booth # 318 and to discuss with our management team your current research needs.
Safe Unsubscribe
This email was sent to info@cureline.com by olga-potapova@cureline.com.
Cureline | 1849 Bayshore Highway | Suite 280 | Burlingame | CA | 94122
